However, an in vitro study indicated that PPAR β/δ‐regulated ANGPTL4 strongly inhibited the transforming growth factor β (TGF β)‐induced invasion of MDA‐MB‐231 human BC cells.44 This evidence concerns the gene ANGPTL4 and breast cancer.